Protocol Ledger

NCT05838716 · Phase III · RECRUITING

Vitamin D for Prostate Endocrine Therapy

Interventional Phase III clinical trial protocol NCT05838716 sponsored by University of Rochester in Oncology and Hematology, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2023-12-14 Enrollment: 240 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT05838716
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)240 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT05838716
Protocol FieldVerified Registry Value
NCT IdentifierNCT05838716
Consolidated Lead SponsorUniversity of Rochester
Therapeutic Condition CohortOncology and Hematology
Clinical Trial PhasePhase III
Overall Recruitment StatusRECRUITING
Registered Enrollment240 participants (ESTIMATED)
Registered Start Date2023-12-14
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI